Cargando…

Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury

BACKGROUND: Clinical dogma is that healthy urine is sterile and the presence of bacteria with an inflammatory response is indicative of urinary tract infection (UTI). Asymptomatic bacteriuria (ABU) represents the state in which bacteria are present but the inflammatory response is negligible. Differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Fouts, Derrick E, Pieper, Rembert, Szpakowski, Sebastian, Pohl, Hans, Knoblach, Susan, Suh, Moo-Jin, Huang, Shih-Ting, Ljungberg, Inger, Sprague, Bruce M, Lucas, Sarah K, Torralba, Manolito, Nelson, Karen E, Groah, Suzanne L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511201/
https://www.ncbi.nlm.nih.gov/pubmed/22929533
http://dx.doi.org/10.1186/1479-5876-10-174
_version_ 1782251554692136960
author Fouts, Derrick E
Pieper, Rembert
Szpakowski, Sebastian
Pohl, Hans
Knoblach, Susan
Suh, Moo-Jin
Huang, Shih-Ting
Ljungberg, Inger
Sprague, Bruce M
Lucas, Sarah K
Torralba, Manolito
Nelson, Karen E
Groah, Suzanne L
author_facet Fouts, Derrick E
Pieper, Rembert
Szpakowski, Sebastian
Pohl, Hans
Knoblach, Susan
Suh, Moo-Jin
Huang, Shih-Ting
Ljungberg, Inger
Sprague, Bruce M
Lucas, Sarah K
Torralba, Manolito
Nelson, Karen E
Groah, Suzanne L
author_sort Fouts, Derrick E
collection PubMed
description BACKGROUND: Clinical dogma is that healthy urine is sterile and the presence of bacteria with an inflammatory response is indicative of urinary tract infection (UTI). Asymptomatic bacteriuria (ABU) represents the state in which bacteria are present but the inflammatory response is negligible. Differentiating ABU from UTI is diagnostically challenging, but critical because overtreatment of ABU can perpetuate antimicrobial resistance while undertreatment of UTI can result in increased morbidity and mortality. In this study, we describe key characteristics of the healthy and ABU urine microbiomes utilizing 16S rRNA gene (16S rDNA) sequencing and metaproteomics, with the future goal of utilizing this information to personalize the treatment of UTI based on key individual characteristics. METHODS: A cross-sectional study of 26 healthy controls and 27 healthy subjects at risk for ABU due to spinal cord injury-related neuropathic bladder (NB) was conducted. Of the 27 subjects with NB, 8 voided normally, 8 utilized intermittent catheterization, and 11 utilized indwelling Foley urethral catheterization for bladder drainage. Urine was obtained by clean catch in voiders, or directly from the catheter in subjects utilizing catheters. Urinalysis, urine culture and 16S rDNA sequencing were performed on all samples, with metaproteomic analysis performed on a subsample. RESULTS: A total of 589454 quality-filtered 16S rDNA sequence reads were processed through a NextGen 16S rDNA analysis pipeline. Urine microbiomes differ by normal bladder function vs. NB, gender, type of bladder catheter utilized, and duration of NB. The top ten bacterial taxa showing the most relative abundance and change among samples were Lactobacillales, Enterobacteriales, Actinomycetales, Bacillales, Clostridiales, Bacteroidales, Burkholderiales, Pseudomonadales, Bifidobacteriales and Coriobacteriales. Metaproteomics confirmed the 16S rDNA results, and functional human protein-pathogen interactions were noted in subjects where host defenses were initiated. CONCLUSIONS: Counter to clinical belief, healthy urine is not sterile. The healthy urine microbiome is characterized by a preponderance of Lactobacillales in women and Corynebacterium in men. The presence and duration of NB and method of urinary catheterization alter the healthy urine microbiome. An integrated approach of 16S rDNA sequencing with metaproteomics improves our understanding of healthy urine and facilitates a more personalized approach to prevention and treatment of infection.
format Online
Article
Text
id pubmed-3511201
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35112012012-12-01 Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury Fouts, Derrick E Pieper, Rembert Szpakowski, Sebastian Pohl, Hans Knoblach, Susan Suh, Moo-Jin Huang, Shih-Ting Ljungberg, Inger Sprague, Bruce M Lucas, Sarah K Torralba, Manolito Nelson, Karen E Groah, Suzanne L J Transl Med Research BACKGROUND: Clinical dogma is that healthy urine is sterile and the presence of bacteria with an inflammatory response is indicative of urinary tract infection (UTI). Asymptomatic bacteriuria (ABU) represents the state in which bacteria are present but the inflammatory response is negligible. Differentiating ABU from UTI is diagnostically challenging, but critical because overtreatment of ABU can perpetuate antimicrobial resistance while undertreatment of UTI can result in increased morbidity and mortality. In this study, we describe key characteristics of the healthy and ABU urine microbiomes utilizing 16S rRNA gene (16S rDNA) sequencing and metaproteomics, with the future goal of utilizing this information to personalize the treatment of UTI based on key individual characteristics. METHODS: A cross-sectional study of 26 healthy controls and 27 healthy subjects at risk for ABU due to spinal cord injury-related neuropathic bladder (NB) was conducted. Of the 27 subjects with NB, 8 voided normally, 8 utilized intermittent catheterization, and 11 utilized indwelling Foley urethral catheterization for bladder drainage. Urine was obtained by clean catch in voiders, or directly from the catheter in subjects utilizing catheters. Urinalysis, urine culture and 16S rDNA sequencing were performed on all samples, with metaproteomic analysis performed on a subsample. RESULTS: A total of 589454 quality-filtered 16S rDNA sequence reads were processed through a NextGen 16S rDNA analysis pipeline. Urine microbiomes differ by normal bladder function vs. NB, gender, type of bladder catheter utilized, and duration of NB. The top ten bacterial taxa showing the most relative abundance and change among samples were Lactobacillales, Enterobacteriales, Actinomycetales, Bacillales, Clostridiales, Bacteroidales, Burkholderiales, Pseudomonadales, Bifidobacteriales and Coriobacteriales. Metaproteomics confirmed the 16S rDNA results, and functional human protein-pathogen interactions were noted in subjects where host defenses were initiated. CONCLUSIONS: Counter to clinical belief, healthy urine is not sterile. The healthy urine microbiome is characterized by a preponderance of Lactobacillales in women and Corynebacterium in men. The presence and duration of NB and method of urinary catheterization alter the healthy urine microbiome. An integrated approach of 16S rDNA sequencing with metaproteomics improves our understanding of healthy urine and facilitates a more personalized approach to prevention and treatment of infection. BioMed Central 2012-08-28 /pmc/articles/PMC3511201/ /pubmed/22929533 http://dx.doi.org/10.1186/1479-5876-10-174 Text en Copyright ©2012 Fouts et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Fouts, Derrick E
Pieper, Rembert
Szpakowski, Sebastian
Pohl, Hans
Knoblach, Susan
Suh, Moo-Jin
Huang, Shih-Ting
Ljungberg, Inger
Sprague, Bruce M
Lucas, Sarah K
Torralba, Manolito
Nelson, Karen E
Groah, Suzanne L
Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury
title Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury
title_full Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury
title_fullStr Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury
title_full_unstemmed Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury
title_short Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury
title_sort integrated next-generation sequencing of 16s rdna and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511201/
https://www.ncbi.nlm.nih.gov/pubmed/22929533
http://dx.doi.org/10.1186/1479-5876-10-174
work_keys_str_mv AT foutsderricke integratednextgenerationsequencingof16srdnaandmetaproteomicsdifferentiatethehealthyurinemicrobiomefromasymptomaticbacteriuriainneuropathicbladderassociatedwithspinalcordinjury
AT pieperrembert integratednextgenerationsequencingof16srdnaandmetaproteomicsdifferentiatethehealthyurinemicrobiomefromasymptomaticbacteriuriainneuropathicbladderassociatedwithspinalcordinjury
AT szpakowskisebastian integratednextgenerationsequencingof16srdnaandmetaproteomicsdifferentiatethehealthyurinemicrobiomefromasymptomaticbacteriuriainneuropathicbladderassociatedwithspinalcordinjury
AT pohlhans integratednextgenerationsequencingof16srdnaandmetaproteomicsdifferentiatethehealthyurinemicrobiomefromasymptomaticbacteriuriainneuropathicbladderassociatedwithspinalcordinjury
AT knoblachsusan integratednextgenerationsequencingof16srdnaandmetaproteomicsdifferentiatethehealthyurinemicrobiomefromasymptomaticbacteriuriainneuropathicbladderassociatedwithspinalcordinjury
AT suhmoojin integratednextgenerationsequencingof16srdnaandmetaproteomicsdifferentiatethehealthyurinemicrobiomefromasymptomaticbacteriuriainneuropathicbladderassociatedwithspinalcordinjury
AT huangshihting integratednextgenerationsequencingof16srdnaandmetaproteomicsdifferentiatethehealthyurinemicrobiomefromasymptomaticbacteriuriainneuropathicbladderassociatedwithspinalcordinjury
AT ljungberginger integratednextgenerationsequencingof16srdnaandmetaproteomicsdifferentiatethehealthyurinemicrobiomefromasymptomaticbacteriuriainneuropathicbladderassociatedwithspinalcordinjury
AT spraguebrucem integratednextgenerationsequencingof16srdnaandmetaproteomicsdifferentiatethehealthyurinemicrobiomefromasymptomaticbacteriuriainneuropathicbladderassociatedwithspinalcordinjury
AT lucassarahk integratednextgenerationsequencingof16srdnaandmetaproteomicsdifferentiatethehealthyurinemicrobiomefromasymptomaticbacteriuriainneuropathicbladderassociatedwithspinalcordinjury
AT torralbamanolito integratednextgenerationsequencingof16srdnaandmetaproteomicsdifferentiatethehealthyurinemicrobiomefromasymptomaticbacteriuriainneuropathicbladderassociatedwithspinalcordinjury
AT nelsonkarene integratednextgenerationsequencingof16srdnaandmetaproteomicsdifferentiatethehealthyurinemicrobiomefromasymptomaticbacteriuriainneuropathicbladderassociatedwithspinalcordinjury
AT groahsuzannel integratednextgenerationsequencingof16srdnaandmetaproteomicsdifferentiatethehealthyurinemicrobiomefromasymptomaticbacteriuriainneuropathicbladderassociatedwithspinalcordinjury